Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: implementation (135), completing (879), finishing (199)

Total body irradiation (TBI) - patient information

Description: This factsheet explains what to expect at your TBI treatment appointments.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Total-body-irradiation-TBI-1332-PIL.pdf

Peptide receptor radionuclide therapy (PRRT) - patient information

Description: This factsheet explains what peptide receptor radionuclide therapy (PRRT) is, what the therapy involves, and what the possible benefits and risks
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/Peptide-receptor-radionuclide-therapy-PRRT-3016-PIL.pdf

Chlorambucil_7_Rituximab

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia (CLL) Chlorambucil (7 day)-Rituximab Regimen • CLL – Chlorambucil (7 day)-Rituximab Indication • Treatment of CLL in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-7-Rituximab.pdf

Chlorambucil_14_Rituximab

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia (CLL) Chlorambucil (14 day)-Rituximab Regimen • CLL – Chlorambucil (14 day)-Rituximab Indication • Treatment of CLL in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-14-Rituximab.pdf

COV001_PIS_v5.0_21_Apr_2020_localised

Description: Southampton NIHR Clinical Research Facility University Hospital Southampton NHS Foundation Trust C Level West Wing, Mailpoint 218 Southampton SO16 6YD Te
Url: /Media/Southampton-Clinical-Research/COVID-19/Vaccine-trial/COV001-PIS-v5.0-21-Apr-2020-localised.docx

Anti-CGRP monoclonal antibodies (mAbs) for the prevention of episodic and chronic migraine - patient information

Description: This factsheet contains information about a preventative treatment for episodic and chronic migraine called anti-CGRP monoclonal antibodies (mAbs).
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/Anti-CGRP-monoclonal-antibodies-mAbs-for-the-prevention-of-episodic-and-chronic-migraine-3075-PIL.pdf

Metformin - patient information

Description: This factsheet explains what metformin is, and what the potential benefits and risks of taking it are.
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Metformin-3180-PIL.pdf

Botox treatment for an overactive bladder - patient information

Description: This factsheet contains information about having Botox treatment for an overactive bladder.
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Botox-treatment-for-an-overactive-bladder-1335-PIL.pdf

Fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) - patient information

Description: This factsheet explains what fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) are and what the tests involve, so that
Url: /Media/UHS-website-2019/Patientinformation/Eyes/Fundus-fluorescein-angiography-FFA-and-indocyanine-green-angiography-ICGA-3796-PIL.pdf

Bulevirtide (Hepcludex®) for the treatment of chronic hepatitis D - patient information

Description: This factsheet explains what bulevirtide (Hepcludex®) is, how it is given to treat hepatitis D and the possible side effects.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Bulevirtide-Hepcludex®-for-the-treatment-of-chronic-hepatitis-D-3673-PIL.pdf

91 to 100 of 1000

Previous … 8 9 10 11 12 … Next